Advertisement

Topics

BS-Partikel GmbH Company Profile

17:29 EST 24th November 2017 | BioPortfolio

BS-Partikel GmbH is engaged in particle synthesis, particle size fractionation, particle analysis and sales of high precision particle standards.
Knowledge, Experiences....
Because of research and development work over many years at university and industry a lot of commercially applied particulate polymer products (e.g. ion exchangers, flocculation aids, GPC/SEC column beads, etc.) could successfully be developed for very different industrial customers. This cumulated comprehensive knowledge combined with effectively improved laboratory technology resulted in highly tailor made polymer particle syntheses and fractionation procedures resulting in monodisperse particles finally.
BS-Partikel GmbH is proud being able to offer monodisperse particle standards with an excellent price/benefit ratio for different applications to all interested customers.

Attitude....
BS-Partikel GmbH is a scientifically driven company trying to give the most supporting information and particulate products you need from a neutral point of judgement. If we can't offer an appropriate solution of our own for your particulate problem we definitely will not propose any innecessary investigation or action for you to be done. So, we sometimes do recommend products of other manufacturers instead of ours if we think they can solve your specific problem significantly better.
Our main goal is to satisfy your needs. Therefore we probably do more than you expect!

We have a (small) research/development department which is permanently looking for new syntheses methods, improved particle fractionation processes and still more precise characterization methods and devices to improve our product quality in general. We also listen to our customers desires and suggestions very carefully to become better in all areas of customers needs. Especially this growing user-friendly relationship enabled us to design new interesting particulate products and services year by year.

Location

Bahnstr. 10
Wiesbaden
D-65205
Germany

Contact

Phone: 49/611/7-888-999
Fax: 49/611/97-218-44
Email: support@BS-Partikel.de


News Articles [121 Associated News Articles listed on BioPortfolio]

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Endocyte licenses radioligand prostate cancer therapy from ABX GMBH

Endocyte Inc. received exclusive global rights to the radioligand therapeutic PSMA617 (177LuPSMA617) from ABX GMBH.

DGAP-News: GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institutional Sales, begleitet und waren signifikant

GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institution.....

Körber Plans Takeover of Systec Services GmbH

     (Photo: http://mma.prnewswire.com/media/558312/SystecServices_Headquarters.jpg) With the planned takeover, Körber Medipak Systems GmbH, the holding company of Business Area Pharma Systems...

Evotec-Aktie: Q3/17 operativ beeindruckend - mehr Innovationen - Kaufen! Aktienanalyse

Frankfurt am Main - Evotec-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, raten in einer aktuellen Aktienanalyse weiterhin zum Kauf ....

Original-Research: Mologen AG (von First Berlin Equity Research GmbH): BUY

Original-Research: Mologen AG - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Mologen AG Unternehmen: Mologen AG ISIN: DE0006637200 Anlass der Studie: Q...

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): BUY

Original-Research: Valneva SE - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Valneva SE Unternehmen: Valneva SE ISIN: FR0004056851 Anlass der Studie: U...

SyncDog Secures Distributor Partner Agreement with Germany-based EBF GmbH for EBF Migrator, EBF’s Platform for Accelerating EMM Migrations

Reston, VA (PRWEB) September 26, 2017 SyncDog, Inc. , the leading ISV for mobile application security, today announced a distributo...

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Pulled-out locking screw re-screwed spontaneously in anterior cervical decompression and fusion with the zero-profile implant system: A case report.

The zero-profile, standalone device (Zero-P, Synthes GmbH, Switzerland) has been reported to be an effective and safe treatment method with similar clinical outcomes compared with plate. Instrumental ...

Cyclic and Torsional Fatigue Resistance of Reciprocating Single Files Manufactured by Different Nickel-titanium Alloys.

The aim of this study was to evaluate the cyclic and torsional fatigue resistance of the following reciprocating single-file systems: ProDesign R 25.06 (Easy Equipamentos Odontológicos, Belo Horizont...

Reliability of a Skin Diagnostic Device in Assessing Hydration and Erythema.

To examine the reliability of a skin diagnostic device, the SD202 (Courage+Khazaka GmBH, Cologne, Germany), in assessing hydration and erythema of periwound skin and pressure injury-prone areas.

Scleral Thinning Documented by Ultrasound Biomicroscopy after Plaque Therapy for Anterior Ciliary Melanoma.

To evaluate, by ultrasound biomicroscopy (UBM), changes in scleral thickness after ruthenium-106 CCB and CCC plaque (Eckert & Ziegler BE-BIG GmbH, Berlin, Germany) therapy for anterior ciliary melanom...

Clinical Trials [39 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Influence of Non-invasive Neurostimulation (Transcutaneous Vagus Nerve Stimulation) on 1. the Noradrenergic Release in the Brain and 2. a Neuropsychological Memory Task

The goal of this study is to investigate the influence of transcutaneous vagus nerve stimulation 1. on the noradrenergic system in the brain and 2. on memory, in healthy volunteers. ...

Companies [523 Associated Companies listed on BioPortfolio]

BS-Partikel GmbH

BS-Partikel GmbH is engaged in particle synthesis, particle size fractionation, particle analysis and sales of high precision particle standards.Knowledge, Experiences....Because of research and devel...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "BS-Partikel GmbH" on BioPortfolio

We have published hundreds of BS-Partikel GmbH news stories on BioPortfolio along with dozens of BS-Partikel GmbH Clinical Trials and PubMed Articles about BS-Partikel GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BS-Partikel GmbH Companies in our database. You can also find out about relevant BS-Partikel GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record